Virax Biolabs Group Ltd. Class A (VRAX)

NASDAQ:VRAX

VRAX

Virax Biolabs Group Ltd. Class A

RESEARCH TOOLSreports

Want to see VRAX full AI Analyst Report?

Compare Virax Biolabs Group Ltd. Class A (VRAX) vs. Competitors

137 Followers

Comparison Results

VRAX

Virax Biolabs Group Ltd. Class A

$0.31

$2.69M

-0.31

-86.89%

―

Biodexa Pharmaceuticals

$2.33

$2.19M

-0.19

-92.96%

―

Scinai Immunotherapeutics

$0.78

$1.88M

-0.20

-80.61%

―

―

Aditxt

$0.43

$105.46K

-0.13

-99.99%

―

Dermata Therapeutics

$2.14

$5.23M

-0.38

-85.09%

1 Buy

0 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

VRAX vs DRMA

xxxxxxxxxxxxx

Performance Comparison

VRAX

Virax Biolabs Group Ltd. Class A

0.14

-0.92

-87.14%

BDRX

Biodexa Pharmaceuticals

4.86

-65.64

-93.11%

SCNI

Scinai Immunotherapeutics

0.54

-2.04

-78.95%

CLSD

―

ADTX

Aditxt

0.12

-1,563.80

-99.99%

DRMA

Dermata Therapeutics

1.30

-6.80

-83.95%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >